Understanding the genetic factors of hidradenitis suppurativa across different races
Multi-racial genetic analysis of hidradenitis suppurativa
This study is looking into hidradenitis suppurativa, a painful skin condition that affects people of different backgrounds, to better understand its causes and find new ways to treat it by comparing the genetics of those with the condition to healthy individuals.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10889138 on NIH RePORTER |
What this research studies
This research investigates hidradenitis suppurativa (HS), a painful skin condition that affects various racial groups, including African Americans, Asians, and Latinos. The study employs advanced techniques such as genome-wide association studies and spatial transcriptomics to explore the genetic and biological factors contributing to HS. By comparing genetic data from affected individuals and healthy controls across different ethnicities, the research aims to uncover new insights into the disease's mechanisms and potential treatment targets.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with hidradenitis suppurativa, particularly those from diverse racial backgrounds.
Not a fit: Patients who do not have hidradenitis suppurativa or those from populations not represented in the study may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and more effective treatments for hidradenitis suppurativa.
How similar studies have performed: Previous research has shown promise in understanding genetic factors in skin diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Liao, Wilson — University of California, San Francisco
- Study coordinator: Liao, Wilson
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.